ProductsDistribution Products

OPTIVATE 1000

Therapeutic indication:

Treatment and prophylaxis of bleeding with hemophilia A (congenital factor VIII deficiency).

  • Composition: Factor VIII 1000 IU/vial, Von willebrand factor 2600 IU/vial
  • Pharmaceutical form: Powder for solution for injection
  • Method of administration: Intravenous
  • Manufacturer: Bio Products Laboratory Limited (BPL)

Join Our Mailing List

Sign up to receive Email updates from Kamada

Latest News

Kamada Reports Continued Profitable Growth with Strong Third Quarter and Nine Month 2024 Financial Results; Raises Full-Year Profitability Guidance
Nov. 13, 2024